N@N

Are PhDs losing their lustre? Why fewer students are enrolling in doctoral degrees

The article from Nature discusses the potential of using artificial intelligence (AI) to enhance the discovery of new antibiotics. It highlights how AI models, trained on vast datasets of microbial genomes and chemical compounds, can predict and identify novel antimicrobial agents. Researchers are employing machine learning algorithms to sift through complex data, aiming to find patterns and connections that could lead to the development of new drugs to combat antibiotic-resistant bacteria. The article also touches on the challenges, such as the need for extensive validation of AI predictions through laboratory experiments, and the ethical considerations of AI in drug discovery. Additionally, it mentions ongoing collaborations between AI experts, microbiologists, and pharmaceutical companies to streamline the process from AI-driven discovery to clinical application.

Read the Full Nature Article at:
[ https://www.nature.com/articles/d41586-025-00425-4 ]